Toggle Nav
Search
Advanced Search
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'all-target'

Search results for: 'all-target'

Shop By
Clear All

Items 1-10 of 43

Page
per page
  1. VS-5584 (SB2343)
    A3927 VS-5584 (SB2343)
    Target: PI3K|mTOR
    Summary: MTOR/P13K inhibitor,potent and selective
      ≥17.7 mg/mL
      ≥4.71 mg/mL
      insoluble in h2o
  2. Trametinib (GSK1120212)
    A3018 Trametinib (GSK1120212)
     7 Citation
    Target: MEK
    Summary: MEK1 and MEK2 inhibitor, potent and selective
      ≥15.38 mg/mL
  3. Panobinostat (LBH589)
    A8178 Panobinostat (LBH589)
     10 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      ≥17.47 mg/mL
      <3.19 mg/mL
      insoluble in h2o
  4. Ispinesib (SB-715992)
    A5343 Ispinesib (SB-715992)
    Target: Ksp
    Summary: Kinesin spindle protein (KSP)inhibitor
      ≥25.85 mg/mL
      ≥48.4 mg/mL
      insoluble in h2o
  5. C646
    B1577 C646
     1 Citation
    Target: p300
    Summary: HAT p300-CBP inhibitor,cell-permeable
      ≥11.1 mg/mL
  6. LDE225 (NVP-LDE225,Erismodegib)
    B2266 LDE225 (NVP-LDE225,Erismodegib)
     1 Citation
    Target: Smoothened
    Summary: Smoothened inhibitor,potent and selective
      ≥24.3 mg/mL
  7. OTSSP167
    B1321 OTSSP167
    Target: MELK
    Summary: MELK inhibitor
      insoluble in dmso
  8. Beta-Lapachone
    B2290 Beta-Lapachone
    Target: Topoisomerases
    Summary: DNA topoisomerase I inhibitor,selective
      ≥10.85 mg/mL
  9. TOK-001
    A8623 TOK-001
    Target: Androgen Receptors|Cytochrome P450 (CYP450)
    Summary: CYP17 inhibitor and androgen receptor (AR) antagonist
      ≥12.4 mg/mL
  10. CCT128930
    A8617 CCT128930
    Target: Akt
    Summary: AKT inhibitor
      ≥17.1 mg/mL

Items 1-10 of 43

Page
per page
Shop By
Now Shopping by
  1. Related Disease Prostate Cancer Remove This Item
Clear All
Shopping Options
Category
Reversibility
  1. Reversible 1 item
  2. Irreversible 2 items
Target
  1. Histone Deacetylases (HDACs) 6 items
  2. Akt 1 item
  3. Bcl-2 2 items
  4. PI3K 1 item
  5. Raf 1 item
  6. Aurora Kinases 1 item
  7. Bcl-xl 2 items
  8. EZH2 2 items
  9. mTOR 2 items
  10. Androgen Receptors 2 items
  11. DT-diaphorases 1 item
  12. LPA Receptors 1 item
  13. VEGFR 1 item
  14. Mcl-1 2 items
  15. MEK 1 item
  16. Smoothened 1 item
  17. Ribosomal s6 kinases (RSK) 1 item
  18. MET 2 items
  19. Src 1 item
  20. EGFR 2 items
  21. JAK 1 item
  22. p300 1 item
  23. HSP90 3 items
  24. Topoisomerases 1 item
  25. Cytochrome P450 (CYP450) 2 items
  26. Ksp 1 item
  27. Survivin 1 item
  28. PKC 1 item
  29. MELK 1 item
  30. Cdc42 1 item
  31. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  32. Androgen Receptor 1 item
Reported Experiments
  1. Animal Experiments 40 items
  2. Cell Experiments 27 items
Related Disease
  1. Acne 1 item
  2. Acute Myelogenous Leukemia 3 items
  3. Acute Myeloid Leukemia 19 items
  4. Adrenocortical Carcinoma 2 items
  5. Advanced Renal Cell Carcinoma 1 item
  6. Autoimmune Diseases 1 item
  7. Biliary Cancer 1 item
  8. Bladder Cancer 7 items
  9. Bladder Carcinoma 2 items
  10. B-lymphoid Malignancies 1 item
  11. Breast Cancer 89 items
  12. Cancer 360 items
  13. Castration-resistant Prostate Cancer 1 item
  14. Cervical Cancer 3 items
  15. Cholangiocarcinoma 1 item
  16. Chronic Lymphocytic Leukemia 4 items
  17. Chronic Myeloproliferative Disorders 1 item
  18. Clear Cell Renal Cell Carcinoma 1 item
  19. Colon Cancer 32 items
  20. Colon Carcinoma 6 items
  21. Colorectal Cancer 30 items
  22. Diabetes 5 items
  23. Diffuse Large B-cell Lymphoma 1 item
  24. Dyskinesia 1 item
  25. Dyslipidemia 1 item
  26. Friedreich's Ataxia 1 item
  27. Fungal Infection 1 item
  28. Fungi 1 item
  29. Glioblastoma 23 items
  30. Glioma 11 items
  31. HCV 5 items
  32. Heart Failure 3 items
  33. Hepatic Cancer 1 item
  34. Hepatitis C 2 items
  35. Hepatocellular Carcinoma 4 items
  36. HIV 11 items
  37. HIV Infections 3 items
  38. Hypercholesterolemia 1 item
  39. Immunological Diseases 1 item
  40. Immunosuppressive Therapy 1 item
  41. Inflammation 1 item
  42. Inflammatory Bowel Disease 1 item
  43. Inflammatory Diseases 4 items
  44. Leukemia 18 items
  45. Liver Cancer 3 items
  46. Lung Cancer 30 items
  47. Lung Carcinoma 4 items
  48. Lymphoma 12 items
  49. Mantle Cell Lymphoma 2 items
  50. Medulloblastoma 1 item
  51. Melanoma 28 items
  52. Mixed Lineage Leukemia 2 items
  53. Multiple Myeloma 15 items
  54. Myelofibrosis 2 items
  55. Myeloma 3 items
  56. Neuroblastoma 7 items
  57. Neuronal Protection 1 item
  58. Non-small Cell Lung Cancer 20 items
  59. Non-small Cell Lung Carcinoma 2 items
  60. Osteoporosis 1 item
  61. Ovarian Cancer 26 items
  62. Pancreatic Cancer 35 items
  63. Pancreatic Carcinoma 2 items
  64. Prostate Cancer 43 items
  65. Psoriasis 3 items
  66. Pulmonary Arterial Hypertension 1 item
  67. Pulmonary Fibrosis 2 items
  68. Pyridyldithiol-activated 1 item
  69. Renal Cancer 5 items
  70. Renal Cell Carcinoma 7 items
  71. Rheumatoid Arthritis 11 items
  72. Schizophrenia 1 item
  73. Sleep Disorders 1 item
  74. Soft Tissue Sarcoma 1 item
  75. Squamous Cell Carcinoma 1 item
  76. Thyroid Cancer 6 items
  77. Tuberculosis 2 items
  78. Type 2 Diabetes 7 items